News headlines about Integer (NYSE:ITGR) have been trending somewhat positive recently, according to Accern. Accern scores the sentiment of news coverage by monitoring more than 20 million news and blog sources in real time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Integer earned a news impact score of 0.11 on Accern’s scale. Accern also gave media headlines about the medical equipment provider an impact score of 44.9662034401481 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the next several days.
Integer (ITGR) opened at $48.55 on Monday. The firm has a market cap of $1,540.00, a P/E ratio of 75.86, a price-to-earnings-growth ratio of 1.02 and a beta of 1.07. Integer has a 12-month low of $29.40 and a 12-month high of $55.20. The company has a debt-to-equity ratio of 1.95, a current ratio of 2.58 and a quick ratio of 1.37.
Integer (NYSE:ITGR) last posted its quarterly earnings results on Thursday, October 26th. The medical equipment provider reported $0.82 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.78 by $0.04. The business had revenue of $363.31 million during the quarter, compared to analyst estimates of $354.83 million. Integer had a net margin of 1.42% and a return on equity of 11.22%. The company’s revenue was up 4.8% on a year-over-year basis. During the same period in the prior year, the business posted $0.83 earnings per share. sell-side analysts anticipate that Integer will post 2.62 EPS for the current year.
In related news, CFO Gary J. Haire sold 731 shares of the company’s stock in a transaction on Wednesday, January 3rd. The shares were sold at an average price of $44.89, for a total transaction of $32,814.59. Following the completion of the transaction, the chief financial officer now owns 1,911 shares in the company, valued at $85,784.79. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, VP Thomas J. Mazza sold 23,123 shares of the company’s stock in a transaction on Thursday, November 9th. The stock was sold at an average price of $46.16, for a total transaction of $1,067,357.68. Following the transaction, the vice president now owns 26,123 shares of the company’s stock, valued at approximately $1,205,837.68. The disclosure for this sale can be found here. Over the last quarter, insiders sold 100,625 shares of company stock valued at $4,694,219. Company insiders own 4.80% of the company’s stock.
ILLEGAL ACTIVITY NOTICE: “Integer (ITGR) Receives Coverage Optimism Rating of 0.11” was first reported by Week Herald and is the sole property of of Week Herald. If you are viewing this piece on another site, it was copied illegally and reposted in violation of U.S. & international trademark and copyright laws. The legal version of this piece can be viewed at https://weekherald.com/2018/01/15/integer-itgr-receives-coverage-optimism-rating-of-0-11.html.
Greatbatch, Inc is a developer and manufacturer of medical devices and components. The Company operates through two segments: Greatbatch Medical and QiG Group (QiG). Greatbatch Medical designs and manufactures products where the Company either owns the intellectual property or has unique manufacturing and assembly expertise.
Receive News & Ratings for Integer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integer and related companies with MarketBeat.com's FREE daily email newsletter.